Day: September 2, 2020

Panostaja Oyj                       Pörssitiedote, sisäpiiritieto                          2.9.2020        klo 9.05       Panostajan sijoituskohde Grano aloittaa yhteistoimintaneuvottelutPanostaja-konserniin kuuluva Grano-konserni aloittaa yhteistoimintaneuvottelut, joiden kohteena on Grano Oy:n markkinoinnin palveluiden, tulostus- ja painotuotteiden tuotannon, logistiikan ja asennustoiminnan sekä myynnin toiminnot ja osa emoyhtiö Grano Group Oy:n toiminnoista. Alustavan arvion mukaan suunnitellut uudelleenjärjestelyt saattavat johtaa enintään 120 henkilön lomauttamiseen, osa-aikaistamiseen tai irtisanomiseen sekä muutoksiin toimintamalleissa ja työtehtävissä. Lisäksi yhtiö harkitsee koko neuvottelun kohteena olevan henkilöstön enintään 90 päivää kestäviä lomautuksia. Mikäli toimenpiteisiin ryhdytään, pyritään ne toteuttamaan viimeistään...

JERSEY CITY, N.J. — Sept. 1, 2020 — Buckle, a tech-enabled financial services company, announced its licensed carrier, the Gateway Insurance Company, has been assigned a Financial Stability Rating® (FSR) of A, Exceptional, from Demotech, Inc. In June, Buckle announced the acquisition and recapitalization of Gateway, including its 47 state insurance licenses. Through its digital fronting strategy™, Buckle has expanded insurance coverage to include transportation network companies (TNCs), traditional taxi, limo, and livery businesses using Lyft, Uber, and other apps. “A Demotech rating enables us to continue the rapid advance of our digital insurance strategies in new and exciting ways,” said Marty Young, co-founder of Buckle. “We purchased, capitalized, seasoned, and relaunched Gateway all in one day. Two months later, we are successfully...

Steve Muehler, the Founder and Senior Managing Member, officially opened the Commercial Real Estate Asset Backed Certificates Market (“CREABC Market”) and the Commercial Multifamily Asset Backed Certificates Market (“CMFABC Market”) to Institutional Real Estate Professionals today. The CREABC Market and the CMFABC Market are two of the three real estate segments of the Private Placement Debt Markets, with the Residential Real Estate Asset Backed Certificates Market scheduled to open on October 1st, 2020. The three real estate segments of the Private Placement Debt Markets were designed to compete head-to-head with the traditional CMBS and MBS markets, and offer an alternative for both brokers, borrowers, investors and lenders working in those markets. Private Placement Markets, the owner and operator of the Private Placement Debt Markets,...

Major indices has ended up market mixed on today’s session as most traders recorded this year’s August as the best for the past three decades. This set to be the best August for the Dow since 1984 so with S&P 500 since 1986. Apple and Tesla are the main contributors of Nasdaq’s performance this Monday market, both shares increasedaround 3% and 12% respectively. Gold and silver also did well while treasuries fell short after traders share different sentiments with regards Federal Reserve not raising interest rates due to falling unemployment rate. Here are the main movements in the Global Stock market; Stocks – S&P 500 snap out of its 7 days passive gain losing around 7.87 points or 0.22% lower to 3,500.14.– The Dow Jones Industrial Average fell short around 226.32 points or 0.79% to 28,427.55.– Nasdaq Composite...

LONDON and RALEIGH, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on Monday, September 14, 2020 at 5:00 PM ET.A live webcast of the event will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and an audio replay will be available there for 30 days.About Verona PharmaVerona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical...

 AttachmentEN_NCX 470 Ph3_adaptive cohort_20200902_F

 Pièce jointeFR _NCX 470 Ph3_adaptive cohort fully enrolled_20200902_F.

Allschwil, Switzerland – September 2, 2020Idorsia Ltd (SIX: IDIA) today informed that the Janssen Pharmaceutical Companies of Johnson & Johnson announced the presentation of additional data on the effect of treatment with ponesimod versus teriflunomide on disability measures in patients with relapsing multiple sclerosis as part of MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting.For further details on the 13 company-sponsored data presentations from its multiple sclerosis research program please read the full announcement from Janssen available at www.janssen.com.Idorsia and Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have entered into a revenue-sharing agreement in respect to ponesimod. Under the terms of the revenue-sharing agreement, Idorsia is entitled to receive quarterly...

Allschwil, Switzerland – September 2, 2020Idorsia Ltd (SIX: IDIA) today informed that the Janssen Pharmaceutical Companies of Johnson & Johnson announced the presentation of additional data on the effect of treatment with ponesimod versus teriflunomide on disability measures in patients with relapsing multiple sclerosis as part of MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting.For further details on the 13 company-sponsored data presentations from its multiple sclerosis research program please read the full announcement from Janssen available at www.janssen.com.Idorsia and Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have entered into a revenue-sharing agreement in respect to ponesimod. Under the terms of the revenue-sharing agreement, Idorsia is entitled to receive quarterly...

Mr. Steve Muehler, Founder & President of Private Placement Markets, today announced the firm would be opening division of the Firm to focus solely on the Aviation & Aerospace Markets. According to Mr. Steve Muehler, “In 2015, that aircraft production industry was worth approximately $180 Billion USD, and at that time no one was thinking that any form of space travel was really on the horizon, let alone having a new private sector focused on space travel with re-usable rockets and a new space military branch. Then in about 2018, private space travel starts to show blips on the radar, improvements or replacement of old airliners starts to kick in, and the industry production value jumps from $180 Billion to give-or-take $270 Billion in 2018, but when combined as the “aerospace and defense” industry, the market was about $374 Billion...